Plasma
Plasma are indispensable biologicals for clinical emergency care and the treatment of multiple diseases. As new therapeutic applications emerge, the industry faces new process challenges in increasing production yield, ensuring product safety, and meeting increasingly stringent regulatory requirements.
In plasma product manufacturing, viral clearance filtration is a core safety step. Alioth's filtration technology is applied not only here, but also throughout plasma component separation, purification, and concentration — helping manufacturers enhance process robustness while meeting the highest quality and regulatory standards.
Process Map
Purple nodes are clickable and lead to Alioth solutions. Gray nodes are informational only.

Cryoprecipitation

Pressure Filtration

Additional Precipitation(Optional)

Dissolution of Fraction ll+IIl Paste

Pressure Filtration

Virus Inactivation

Bioburden Reduction
View solution
Ultrafiltration/Diafiltration(Optional)

Dissolution of Fraction ll Paste

Dissolution of Fraction ll Paste

pH Adjustment

Bioburden Reduction
View solution
Anion Exchange Chromatography

Bioburden Reduction
View solution
Virus Filtration

Final Filling

Sterile Filtration
View solution
Final Formulation

Ultrafiltration/Diafiltration(Optional)
Related Products
Application Notes
Impurity Adsorption Studies for Alioth Alidep® Depth Filters(II)
Does your filter really "Sterilizing"? The New PDA TR26 Redefines the Answer
How to Select Liquid Sterilizing Filters? Your Ultimate Guide Awaits
From a regulatory perspective, the concept and master plan for sterilizing filter validation
2025 NMPA Annex on Sterile Medicinal Products: Requirements for Sterilizing Filtration and Challenges Faced by Enterprises
Why is a 0.22μm Pore Size Used for Sterilizing Filters?
New product launch | Alipore® DHC PES Sterilizing-Grade Hydrophilic Filter
Scalability Studies for Alioth Alidep® Depth Filters
Contact Us
Leave a message for consultation or support, and we will contact you promptly.






